📦 NDC / package directory — not a drug information page
Atoltivimab, Maftivimab, And Odesivimab-Ebgn NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Atoltivimab, Maftivimab, And Odesivimab-Ebgn products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
2
Package NDCs
2
Products
2
Active listings
0
Discontinued
1
Labelers
2
Strengths
1
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 2 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Inmazeb atoltivimab, maftivimab, and odesivimab-ebgn 241.7 mg/14.5mL; 241.7 mg/14.5mL; 241.7 mg/14.5mL INJECTION, SOLUTION | 61755-0018-01 | — | On market | View → |
| Inmazeb atoltivimab, maftivimab, and odesivimab-ebgn 483.3 mg/14.5mL; 483.3 mg/14.5mL; 483.3 mg/14.5mL INJECTION, SOLUTION | 61755-0019-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.